Innovation
1 patent family — focus: Human necessities; filing pace steady. Cited 3 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
Investor mix
1 investor on record; lead investors include Safar Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developer of therapies to treat ocular surface disease
1 patent family — focus: Human necessities; filing pace steady. Cited 3 times.
| Year | Filings |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
1 investor on record; lead investors include Safar Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |